Human rights in manufacturing and distribution

Drugs manufacturing and distribution operations range from the production of active ingredient(s), the manufacturing of the finished
product (including the procurement of excipients and raw materials from suppliers), as well as its storage and distribution to wholesalers, hospitals and retail pharmacies. These operations can be fully or partly managed by pharmaceutical companies or third parties.

  • Manage provision of life-saving drugs to
    ensure a continuous supply inadequate
    quantities to patients in need
  • Provide complete, updated and understandable
    information on drugs packaging and labeling
  • Respond in a timely manner to humanitarian
    emergencies and provide access to healthcare
    for the injured, the displaced and evacuees
  • click to see example
  • Limit the impacts of production
    and distribution processes on the
    environment and local communities

Key Stakeholders

Patient and
patient associations 

Healthcare professionals
and scientific community 

Health authorities, governments
and international institutions 
NGOs and
non-profit organizations 

Local communities
and citizens 



Example of Sanofi's good practices

Identify all natural resources used in production processes and coordinate with local stakeholders
to implement specific programs for the protection of biodiversity, the local economy and ecosystems.

  • Sanofi established a program with the Institute for one World Health (ioWH) to manufacture semisynthetic artemisinin, an active ingredient in Sanofi’s first-line
    malaria treatment, on an industrial scale. By replacing natural artemisinin, made from sweet wormwood leaves, the program helps secure a constant raw material supply, prevents price speculation among local farmers, and preserves local biodiversity and agricultural equilibrium in the food supply for local populations.

Human Rights

Right to dispose freely of one's natural resources /
right to benefit from a healthy environment

Right to property